| Dr Sarah Lynn Sarubbi, PSYD | |
|
200 Tarpon Trl, Jacksonville, NC 28546-5287 | |
| (910) 938-1114 | |
| (910) 938-1118 |
| Full Name | Dr Sarah Lynn Sarubbi |
|---|---|
| Gender | Female |
| Speciality | Clinical Psychologist |
| Experience | 12 Years |
| Location | 200 Tarpon Trl, Jacksonville, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245582956 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Coastal Carolina Neuropsychiatric Center Pa | 5890794689 | 31 |
News Archive
Treatment for alcohol use disorders works best if the patient actively understands and incorporates the interventions provided in the clinic.
Seventh graders given 20 mg zinc, five days per week, for 10 to 12 weeks showed improvement in mental performance, responding more quickly and accurately on memory tasks and with more sustained attention, than classmates who received no additional zinc.
Eli Lilly and Company and Hypnion, Inc. today announced that they have signed a definitive merger agreement whereby Lilly will acquire Hypnion, a privately held neuroscience drug discovery company focused on sleep disorders.
An unfortunate side effect of the platinum-chemotherapy drug oxaliplatin is the development of neurotoxicity, which can adversely affect a patient's quality of life; therefore, the benefit of oxaliplatin-based therapy must be balanced with prevention of neuropathies. Currently, there are no therapeutic interventions available to relieve oxaliplatin-associated neurological symptoms, which are thought to be a result of reactive oxygen species-associated damage.
› Verified 6 days ago
| Entity Name | Coastal Carolina Neuropsychiatric Center Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184737462 PECOS PAC ID: 5890794689 Enrollment ID: O20061205000123 |
News Archive
Treatment for alcohol use disorders works best if the patient actively understands and incorporates the interventions provided in the clinic.
Seventh graders given 20 mg zinc, five days per week, for 10 to 12 weeks showed improvement in mental performance, responding more quickly and accurately on memory tasks and with more sustained attention, than classmates who received no additional zinc.
Eli Lilly and Company and Hypnion, Inc. today announced that they have signed a definitive merger agreement whereby Lilly will acquire Hypnion, a privately held neuroscience drug discovery company focused on sleep disorders.
An unfortunate side effect of the platinum-chemotherapy drug oxaliplatin is the development of neurotoxicity, which can adversely affect a patient's quality of life; therefore, the benefit of oxaliplatin-based therapy must be balanced with prevention of neuropathies. Currently, there are no therapeutic interventions available to relieve oxaliplatin-associated neurological symptoms, which are thought to be a result of reactive oxygen species-associated damage.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sarah Lynn Sarubbi, PSYD 200 Tarpon Trl, Jacksonville, NC 28546-5287 Ph: (910) 938-1114 | Dr Sarah Lynn Sarubbi, PSYD 200 Tarpon Trl, Jacksonville, NC 28546-5287 Ph: (910) 938-1114 |
News Archive
Treatment for alcohol use disorders works best if the patient actively understands and incorporates the interventions provided in the clinic.
Seventh graders given 20 mg zinc, five days per week, for 10 to 12 weeks showed improvement in mental performance, responding more quickly and accurately on memory tasks and with more sustained attention, than classmates who received no additional zinc.
Eli Lilly and Company and Hypnion, Inc. today announced that they have signed a definitive merger agreement whereby Lilly will acquire Hypnion, a privately held neuroscience drug discovery company focused on sleep disorders.
An unfortunate side effect of the platinum-chemotherapy drug oxaliplatin is the development of neurotoxicity, which can adversely affect a patient's quality of life; therefore, the benefit of oxaliplatin-based therapy must be balanced with prevention of neuropathies. Currently, there are no therapeutic interventions available to relieve oxaliplatin-associated neurological symptoms, which are thought to be a result of reactive oxygen species-associated damage.
› Verified 6 days ago
Mrs. Jameszetta Hardison, LPA LMFT Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1703 Country Club Rd, Suite 204, Jacksonville, NC 28546 Phone: 910-347-3010 Fax: 910-347-3201 | |
Carissa Marsh, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 200 Doctors Dr Ste M, Jacksonville, NC 28546 Phone: 910-378-2678 Fax: 910-900-0930 | |
Mrs. Erin Lesko, LPA Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1703 Country Club Rd, Suite 204, Jacksonville, NC 28546 Phone: 910-347-3010 Fax: 910-347-3201 | |
Dr. Cheryl Ann Morrow-bradley, PH.D Psychologist Medicare: Accepting Medicare Assignments Practice Location: 2444 Commerce Rd, Ste 125, Jacksonville, NC 28546 Phone: 910-238-2166 Fax: 910-333-0639 | |
Ms. Joyce M. Harpe, M.A., LPA Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1703 Country Club Rd, Suite 204, Jacksonville, NC 28546 Phone: 910-347-3010 | |
Jonathan Marmorstein, MA, LPA Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1703 Country Club Rd, Suite 204, Jacksonville, NC 28546 Phone: 910-347-3010 Fax: 910-347-3201 |